Novo Nordisk Criticized for Weight-Loss Drug Side Effect Reporting
Dayton News Today | 2 Min News | The Daily News Now! · The Daily News Now!
Audio is streamed directly from the publisher (api.fastcast.ai) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Novo Nordisk faces FDA scrutiny for failing to report serious side effects from Ozempic and Wegovy, including three unreported deaths. The FDA has issued a warning, citing lapses in investigation and reporting. Novo Nordisk has pledged to implement corrective measures, but the FDA is demanding more detailed steps to prevent future issues.
Support the show:
Get a discount at https://solipillow.com/discount/dnn.
Advertise on DNN:
[email protected]
This is an automated, high-level news summary based on public reporting.
Report issues to [email protected].
View sources & latest updates:
https://sources.thednn.ai/5f0c3d11b7d629f2